April 2016

Feature

From the Field

Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center

04/11/2016

Aymen Elfiky, MD, MPH, MSc

Marina Kaymakcalan, PharmD

Abstract: The rising costs associated with cancer care delivery have prompted the health care system to prioritize the principle of value-based care to accentuate the concepts of quality and outcomes. Driven in...

...

04/11/2016

Journal of Clinical Pathways

Research Reports

Health Care Use and Costs Among Medicare Patients With Chronic Obstructive Pulmonary Disease Treated With Short-Acting Beta Agonists or Long-Acting Beta Agonists

04/11/2016

Flavia Ejzykowicz, PhD

Vamsi K Bollu, PhD, MBA

Krithika Rajagopalan, PhD

Joel W Hay, PhD

Abstract: Chronic obstructive pulmonary disease (COPD) has a high prevalence among older adults and is the third leading cause of mortality in the United States. COPD exacerbations can require hospitalizations,...

...

04/11/2016

Journal of Clinical Pathways

Column

Clinical Pathways GPS

Adding Patient Navigation to the Clinical Pathway for Alzheimer Disease

04/11/2016

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Harold Freeman, MD

Ruth Gay

Mary Michael

David Digby

Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...

...

04/11/2016

Journal of Clinical Pathways

Pharma Insights

When Medication Price Deflates Perception of Therapeutic Effect

04/11/2016

Larry Blandford, PharmD—Column Editor

Stephen C Carter

Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...

...

04/11/2016

Journal of Clinical Pathways

Insights

Interview

Devising Pathways Strategies That Maintain the Principles of Personalized Medicine

04/11/2016

JCP Editors

As clinical pathways are utilized by more institutions to provide standardized, evidence-based care for patients with cancer, these tools have demonstrated a clear ability to reduce costs,1 improve hospital...

As...

04/11/2016

Journal of Clinical Pathways

News

Conference Coverage

Association of Community Cancer Centers Annual Meeting: CANCERSCAPE 2016

04/11/2016

JCP Editors

Since its formation, the Association of Community Cancer Centers (ACCC) has become integral to disseminating oncology standards and new clinical protocols to community cancer programs around the United States. The...

Since...

04/11/2016

Journal of Clinical Pathways

Department

Research in Review

Evidence-Based Training to Improve Physician Responses to Adverse Events

04/11/2016

JCP Editors

A study published in BMC Medical Education has found that an online game can be an effective and acceptable way to train junior doctors in care relating to adverse events from cancer treatment and increase their...

...

04/11/2016

Journal of Clinical Pathways

Research in Review

Number of Positive Nodes Best Prognostic Indicator for Patients With Head and Neck Cancer

04/11/2016

JCP Editors

The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...

The...

04/11/2016

Journal of Clinical Pathways

Research in Review

Pathways for Urologic Surgery Potentially Beneficial, Though More Research is Needed

04/11/2016

JCP Editors

An overview of enhanced recover after surgery (ERAS) pathways has identified some of the key benefits and needs for future research of the programs for patients who receive urological surgery.  ERAS programs...

An...

04/11/2016

Journal of Clinical Pathways

Research in Review

New Clinical Pathways Definition Developed to Help Guide Future Research

04/11/2016

JCP Editors

Using the foundation of past studies, researchers have described the process for developing, refining, and pilot testing a set of criteria for a practical operational definition of clinical pathways in health...

Using...

04/11/2016

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

April 2016

Feature

Column

Insights

News

Department

Current Issue

Special Reports

Subscribe

April 2016 Volume 2

Specialties

Events

Year Round Education

HMP Global Products